IL6 and hereditary sensory and autonomic neuropathy: One study identified elevated levels of C-reactive protein and interleukin-6 in patients with atezolizumab-induced CIP when compared with baseline levels (Abdul Rafeh Naqash LVYSanderlin et al., 2018).